Original language | English |
---|---|
Pages (from-to) | 375-375 |
Journal | Journal of Clinical Oncology |
Volume | 30 |
Issue number | 5_suppl |
DOIs | |
Publication status | Published - 10 Feb 2012 |
Externally published | Yes |
What is the best treatment option for second line in long responders to the first-line TKI in metastatic renal cell carcinoma (mRCC) patients (pts): TKI-TKI or TKI-mTORi? A European retrospective study.
Reza-Thierry Elaidi, Benoit Beuselinck, Agnes Maj-HES, Delphine Carmier, Aristotelis Bamias, Philip R. Debruyne, Camillo Porta, Sophie Roca, Stephane Oudard
Research output: Contribution to journal › Article › peer-review